Are corticosteroid injections needed after needling and lavage of calcific tendinitis? Randomised, double-blind, non-inferiority trial.
Acute Pain
/ etiology
Adult
Calcinosis
/ diagnostic imaging
Double-Blind Method
Equivalence Trials as Topic
Female
Follow-Up Studies
Glucocorticoids
/ adverse effects
Humans
Injections, Intra-Articular
Male
Methylprednisolone
/ adverse effects
Middle Aged
Pain Measurement
/ methods
Pain, Postoperative
/ etiology
Punctures
/ adverse effects
Rotator Cuff
Saline Solution
Shoulder Pain
/ diagnostic imaging
Tendinopathy
/ diagnostic imaging
Therapeutic Irrigation
/ methods
Treatment Outcome
Ultrasonography, Interventional
corticosteroids
tendinitis
ultrasonography
Journal
Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355
Informations de publication
Date de publication:
06 2019
06 2019
Historique:
received:
21
12
2018
revised:
19
03
2019
accepted:
20
03
2019
pubmed:
13
4
2019
medline:
30
1
2020
entrez:
13
4
2019
Statut:
ppublish
Résumé
Steroid injections are common after an ultrasound-guided puncture and lavage (UGPL) of calcific tendonitis of the rotator cuff. However, steroids may prevent calcification resorption and negatively affect tendon healing. Our study was designed to determine whether saline solution was non-inferior to steroids in the prevention of acute pain reactions in the week following UGPL. This was a randomised, double-blinded, controlled non-inferiority trial with 12-month follow-up. We included 132 patients (66 in each group) with symptomatic calcification measuring more than 5 mm. Patients received 1 mL of saline or steroid (methylprednisolone 40 mg) in the subacromial bursa at the end of UGPL. Primary outcome was the maximal pain during the week following the procedure with a prespecified non-inferiority margin of 10 mm (0-100 visual analogue scale). Secondary outcomes included pain at rest and during activity, function (disabilities of the arm, shoulder and hand score) and radiological evolution of the calcification over the 12-month follow-up. The estimated mean difference in the first week's maximal pain between these two groups was 11.76 (95% CI 3.78 to 19.75). Steroids significantly improved VAS pain at rest and during activities, as well as function at 7 days and 6 weeks. They did not change the rate of calcification resorption, which occurred in 83% and 74% of patients at 12 months in the saline and steroid groups. Non-inferiority of saline when compared with steroids could not be established. However, steroid injection improved pain in the 6 weeks following the procedure, and function in the 3 months after, with no significant effect on calcification resorption. NTC02403856.
Identifiants
pubmed: 30975645
pii: annrheumdis-2018-214971
doi: 10.1136/annrheumdis-2018-214971
doi:
Substances chimiques
Glucocorticoids
0
Saline Solution
0
Methylprednisolone
X4W7ZR7023
Banques de données
ClinicalTrials.gov
['NCT02403856']
Types de publication
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
837-843Informations de copyright
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.